Bosch M, Akhter A, Chen BE, Mansoor A, Lebrun D, Good D, Crump M, Shepherd L, Scott DW, Stewart DA. A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. Haematologica [Internet]. 2018Jan.31 [cited 2026Nov.14];103(2):288-96. Available from: https://haematologica.org/article/view/8351